rdf-syntax-grammar
mods:
  schema location: http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
  title info:
    title: Heomatopoietic cell transplantation for malignant conditions
  name:
    name part: Bashir, Qaiser.
  name:
    name part: Hamadani, Mehdi.
  name:
    name part: ScienceDirect (Online service)
  type of resource: text
  genre: Electronic books.
  origin info:
    place:
      place term: mou
    place:
      place term: St. Louis, Missouri
    publisher: Elsevier
    date issued: ©2019
    date issued: 2019
    issuance: monographic
  language:
    language term: eng
  physical description:
    form: remote
    extent: 1 online resource
  abstract: Get a quick, expert overview of hematologic and non-hematologic malignancies for which hematopoietic cell transplantation is a treatment option. Drs. Qaiser Bashir and Mehdi Hamadani provide easy-to-find information on basic science of hematopoietic cell transplantation, pharmacology, workflows and procedures, possible complications and side effects, in addition to the role of HCT in conjunction with clinical cellular therapy. Discusses high-dose chemotherapeutic regimens and radiation therapy, patient and donor selection and workup, as well as other key aspects of hematopoietic cell transplantation. Includes practical information on complications, infectious disease, and special populations such as patients with HIV infection. Consolidates today's available information in this fast-changing area into one convenient resource.
  table of contents: Front Cover; Hematopoietic Cell Transplantation for Malignant Conditions; Hematopoietic Cell Transplantation for Malignant Conditions; Copyright; List of Contributors; Contents; I -- HISTORY AND BASIC SCIENCE OF HEMATOPOIETIC CELL TRANSPLANTATION; 1 -- History and Current Status of Hematopoietic Cell Transplantation; INTRODUCTION; BMT Developments in 1950s to Early 1960s; The Significance of HLA Matching in Transplant; Late 1960s: The First Successful HLA-Matched Sibling BMTs; Late 1970s to Mid-1980s: Use of Unrelated Donors; 1980−90: Use of PB as Autograft
  table of contents: Early 1990s: Rapid Increase in Allogeneic Transplantation Using PB GraftsHaploidentical Stem Cell Transplantation; History of Umbilical Cord Blood Transplant; Late 1990s to Early 2000s: Introduction of RIC; Origin of Donor and Transplant Registries; CONCLUSION; REFERENCES; II -- HEMATOPOIETIC CELL TRANSPLANTATION PHARMACOLOGY; 2 -- Pharmacology of Drugs Used in Hematopoietic Cell Transplantation; INTRODUCTION; IMMUNOSUPPRESSANTS; Cyclosporine; Pearls; Tacrolimus; Pearls; Methotrexate; Mycophenolate; Sirolimus; Pearls; Cyclophosphamide; Antithymocyte Globulin; Pearls; Alemtuzumab; Pearls
  table of contents: CorticosteroidsPearls; ANTIMICROBIAL AGENTS; Trimethoprim/Sulfamethoxazole; Piperacillin/Tazobactam; Pearl; Cephalosporins; Carbapenems; Vancomycin; Pearl; Metronidazole; Antivirals; Antifungals; ANTIDIARRHEAL AGENTS; Loperamide; Diphenoxylate and Atropine; Octreotide; MISCELLANEOUS; Defibrotide; Ursodiol; Deferasirox; Intravenous Immune Globulin; Palifermin; REFERENCES; 3 -- High-Dose Chemotherapy Regimens; GOALS OF CONDITIONING REGIMENS; TYPES OF CONDITIONING REGIMENS; NONCHEMOTHERAPY AGENTS IN CONDITIONING REGIMENS; Total-Body Irradiation; Radioisotopes and Radioimmunotherapy
  table of contents: 90Y-Ibritumomab TiuxetanCHEMOTHERAPY AGENTS IN CONDITIONING REGIMENS; ALKYLATING AGENTS; Busulfan; Cyclophosphamide; Ifosfamide; Melphalan; Thiotepa; Carmustine; Bendamustine; ANTIMETABOLITES; Fludarabine; Clofarabine; Cytarabine; Gemcitabine; PLATINUM AGENTS; Carboplatin; PLANT ALKALOIDS; Etoposide; ANTI-T CELL ANTIBODIES; MONOCLONAL ANTIBODIES; Rituximab; DOSING CONSIDERATIONS; Organ Dysfunction; Renal; Hepatic; Dosing Principles; Dosing in Obese Patients; REFERENCES; 4 -- The Role of Radiation Therapy in Hematopoietic Stem Cell Transplantation; TOTAL-BODY IRRADIATION THERAPY
  table of contents: Myeloablative Conditioning RegimensReduced-Intensity Conditioning Regimens; CNS Leukemic Involvement; Toxicity after HSCT: contributions from TBI; THE ROLE OF RT AMONG PATIENTS WITH HODGKIN LYMPHOMA AND NON-HODGKIN LYMPHOMA UNDERGOING HSCT; Hodgkin Lymphoma; Non-Hodgkin Lymphoma; Toxicity Among HL and NHL Patients; CONCLUSIONS; DISCLOSURE STATEMENT; REFERENCES; III -- WORKFLOWS AND PROCEDURES IN HEMATOPOIETIC CELL TRANSPLANTATION; 5 -- Sources of Cells for Hematopoietic Cell Transplantation: Practical Aspects of Hematopoietic Cell Collection; INTRODUCTION
  note: edited by Qiaser Bashir, Mehdi Hamadani.
  note: SOURCES OF CELLS FOR ALLOGENEIC TRANSPLANTATION
  subject:
    topic: Stem cells
    topic: Therapeutic use
  subject:
    topic: Hematopoietic Stem Cell Transplantation
    topic: methods
  subject:
    topic: Hematologic Neoplasms
    topic: therapy
  subject:
    topic: Cellules souches
    topic: Emploi en thérapeutique
  subject:
    topic: Cancer
    topic: Chemotherapy
  subject:
    topic: Hematopoietic stem cells
    topic: Transplantation
  classification: QH588.S83
  classification: 616.02/774
  classification: 2019 D-070
  classification: WH 380
  related item:
    identifier: (OCoLC)1004256216
  identifier: 9780323568036
  identifier: 0323568033
  identifier: 0323568025
  identifier: 9780323568029
  identifier: 9780323568036 Ingram Content Group
  identifier: http://proxy.library.tamu.edu/login
  record info:
    record content source: YDX
    record creation date: 190309
    record change date: 20260327154620.2
    record identifier: in00005764507
    language of cataloging:
      language term: eng